Bavarian Nordic crashes out of RSV race after phase 3 trial

FierceBiotech - 24 Jul 2023
Bavarian Nordic has crashed out of the respiratory syncytial virus vaccine race, with a phase 3 failure sending the company's plans—and stock price—into a ...

Bavarian Nordic raises sales guidance after monkeypox vaccine order

Yahoo Movies UK - 18 Apr 2024
Bavarian Nordic raises sales guidance after monkeypox vaccine order ...

UPDATED: Bavarian Nordic begins commercial launch of mpox vaccine Jynneos in US

FiercePharma - 02 Apr 2024
UPDATED: Bavarian Nordic begins commercial launch of mpox vaccine Jynneos in US ...

Bavarian Nordic announces commercial launch of mpox vaccine

University of Minnesota Twin Cities - 02 Apr 2024
Bavarian Nordic announces commercial launch of mpox vaccine ...

Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S

GlobeNewswire - 16 Apr 2024
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S ...

Bavarian Nordic’s chikungunya vaccine secures EMA fast-track

Pharmaceutical Technology - 23 Feb 2024
Bavarian Nordic’s chikungunya vaccine secures EMA fast-track ...

First Commercial Distributor Readies Bavarian Nordic's U.S. FDA-approved Mpox Vaccine

Precision Vaccinations - 04 Apr 2024
First Commercial Distributor Readies Bavarian Nordic's U.S. FDA-approved Mpox Vaccine ...

Bavarian Nordic Puts Kibosh on Cancer Vaccine, Focuses on Infectious Diseases

BioSpace - 21 Feb 2024
Bavarian Nordic Puts Kibosh on Cancer Vaccine, Focuses on Infectious Diseases ...

Bavarian Nordic halts cancer vaccine program

Fierce Biotech - 21 Feb 2024
Bavarian Nordic halts cancer vaccine program ...

US CDC recommends routine use of Bavarian Nordic mpox vaccine for adults at risk

Reuters - 26 Oct 2023
US CDC recommends routine use of Bavarian Nordic mpox vaccine for adults at risk ...

Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Crosses Below Two Hundred Day Moving Average of $7.60

MarketBeat - 18 Apr 2024
Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Crosses Below Two Hundred Day Moving Average of $7.60 ...

Bavarian Nordic Hones Infectious Disease Focus by Dropping Cancer Vaccine R&D

MedCity News - 21 Feb 2024
Bavarian Nordic Hones Infectious Disease Focus by Dropping Cancer Vaccine R&D ...

Bavarian Nordic A/S Issues New Shares in Connection with Exercise of Warrants

Yahoo News UK - 18 Apr 2024
Bavarian Nordic A/S Issues New Shares in Connection with Exercise of Warrants ...

Bavarian Nordic: Bringing manufacturing home - BioProcess Insider

BioProcess Insider - 29 Feb 2024
Bavarian Nordic: Bringing manufacturing home - BioProcess Insider ...

Bavarian Nordic’s revenue soars post-mpox outbreaks

Pharmaceutical Technology - 21 Feb 2024
Bavarian Nordic’s revenue soars post-mpox outbreaks ...

Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.

GlobeNewswire - 02 Apr 2024
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S. ...

Bavarian Nordic expands access to mpox vaccine in US

Pharmaceutical Technology - 02 Apr 2024
Bavarian Nordic expands access to mpox vaccine in US ...

Bavarian Nordic to Host First Quarter 2017 Results Conference Call

Yahoo News UK - 17 Apr 2024
Bavarian Nordic to Host First Quarter 2017 Results Conference Call ...

US recommends Bavarian Nordic's mpox vaccine for routine use

Pharmaceutical Technology - 26 Oct 2023
US recommends Bavarian Nordic's mpox vaccine for routine use ...

Bavarian Nordic Publishes Annual Report 2023

Yahoo Finance - 06 Mar 2024
Bavarian Nordic Publishes Annual Report 2023 ...

Bavarian Nordic